If you IPO'd, uplisted, or de-SPAC'd with your equity records in Carta, nothing broke on listing day. That is exactly why the gap sneaks up on teams: the tool keeps working while the requirements change underneath it. Before listing, the equity questions were "what is the cap table?" and "what is the 409A strike price?" After listing, the questions come from your auditor and your 10-Q: what is the ASC 718 expense this quarter, show me the rollforward, and where are the footnote disclosures?
What Carta remains genuinely great at
- System of record for grants. Board approvals, grant documents, vesting schedules, exercises, e-signatures: clean, mature workflow.
- Private-market DNA that still helps. If you have legacy SAFEs converting, warrants from crossover rounds, or subsidiaries with their own equity, the historical record in Carta is valuable and worth preserving.
- Employee experience. Holders see their grants and vesting in a polished portal, which reduces a steady tax on HR and finance time.
- The private-company suite. 409A valuations, fundraising and SAFEs, scenario modeling: category-defining, and simply not the post-listing problem.
What changes when you are public
- 409A ends; ASC 718 discipline begins. You have a market price now. The valuation question moves to grant-date fair value for expense (Black-Scholes inputs for options, market price for RSUs), and the deliverable is an expense schedule and footnote package your auditor ties out every quarter.
- The filings need specific outputs. Activity rollforwards for the period, weighted-average data, assumptions for awards granted, unrecognized compensation cost and the remaining recognition period. These land in the 10-K and 10-Q on the deadlines covered in our deadline guides, whether or not the schedule is ready.
- New actors take over settlement. Transfer agent, brokers, and your plan's S-8 handle the share mechanics that a private cap table platform used to own end to end.
- Proxy and Section 16 gravity. Compensation tables, equity plan proposals, and insider reporting all pull from the same grant data, and inconsistencies between them get noticed.
Keep Carta if / add Unfolding Equity if
| Keep Carta if… | Add Unfolding Equity if… |
|---|---|
| You want a polished holder portal and mature grant-issuance workflow | Quarterly ASC 718 expense and disclosure schedules are built by hand in Excel |
| Legacy private-market instruments (SAFEs, crossover warrants) still need their historical record | Your auditor's equity PBC list takes days each quarter to assemble |
| HR owns equity administration and likes the current workflow | The reporting team needs filing-ready rollforwards, assumptions, and unrecognized-cost outputs on the 10-Q clock |
| You are early enough post-listing that migration risk outweighs tooling gaps | You are a small filer and want fixed, predictable pricing for the reporting layer |
| Budget already covers it and the export workflow is genuinely controlled | Grant tracking and filing-readiness should live where the filings are prepared, reviewed, and signed |
Note the framing: this is mostly not a rip-and-replace decision. The clean pattern we see work is Carta as the administration record, Unfolding Equity as the disclosure layer the reporting team owns, and a reconciliation between them each quarter. Companies that later consolidate do it deliberately, after a clean year of filings, not in a panic during close.
Where Unfolding Equity fits
Unfolding Equity is built for exactly one customer: the small US-listed company whose equity-comp disclosure has outgrown spreadsheets but whose budget does not justify enterprise equity administration. Grant and RSU tracking oriented to the outputs a 10-K and 10-Q actually require, ASC 718 filing-readiness, fixed pricing, and no per-employee charges. It is designed by the same US CPA, who has led finance and accounting for a US-listed public company, who builds the free tools on this site, and it connects to the same discipline: the 10-Q disclosure assessment includes the stock-compensation sections, so you can see your gap before you buy anything.
Run the free 10-Q disclosure assessment and look at the ASC 718 sections. If your current stack produces those answers easily, you do not need us yet. If it does not, you have found the gap.
Run the free 10-Q assessment →FAQ
Do we have to leave Carta after going public?
No. Keep it for administration if it is working. The question is who produces the ASC 718 disclosure layer, because that job now exists every quarter regardless.
What actually changes at listing?
409A ends, market price takes over, settlement moves to the transfer agent ecosystem, and the deliverables become filing disclosures on SEC deadlines: rollforwards, assumptions, unrecognized cost, proxy tables, Section 16.
Can Carta and Unfolding Equity run together?
Yes, and that is the common pattern: administration record in Carta, disclosure and filing-readiness layer in Unfolding Equity, reconciled quarterly.
What does ASC 718 disclosure require each period?
In broad terms: recognized compensation cost, activity rollforwards, valuation assumptions for new grants, and unrecognized cost with the remaining recognition period. Your auditor ties each to supporting schedules. Confirm specifics for your facts with your auditor.
What does Unfolding Equity cost?
Fixed annual pricing, published on the product page, with no per-employee charges. Pricing for third-party products mentioned here changes; verify with each vendor.
Recently public and unsure whether your equity stack survives its first audit cycle? That is a conversation we have often, and honestly. Talk to us.